Find Ranitidine Bismuth Citrate manufacturers, exporters & distributors on PharmaCompass

Ranitidine Bismuth Citrate

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 FDA Orange Book

1 FDF Dossiers
1 FDA Orange Book

DIGITAL CONTENT

2 NEWS #PharmaBuzz

media
2 NEWS #PharmaBuzz

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

patents
1 Health Canada Patents

ANALYTICAL

1 BioAnalytical Methods

otherMethods
1 BioAnalytical Methods

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Ranitidine bismutrex, Tritec, Gr 122311x, Gr-122311x, 7aj51i17kg, 128345-62-0

Molecular Formula

C₁₉H₂₇BiN₄O₁₀S

Molecular Weight

712.5 g/mol

InChI Key

XAUTYMZTJWXZHZ-UHFFFAOYSA-K

FDA UNII

7AJ51I17KG

Ranitidine Bismuth Citrate is a member of the class of histamine H2-receptor antagonists with antacid activity. Ranitidine is a competitive and reversible inhibitor of the action of histamine, released by enterochromaffin-like (ECL) cells, at the histamine H2-receptors on parietal cells in the stomach, thereby inhibiting the normal and meal-stimulated secretion of stomach acid. In addition, other substances that promote acid secretion have a reduced effect on parietal cells when the H2 receptors are blocked.

1 2D Structure

Ranitidine Bismuth Citrate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

bismuth;1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine;2-hydroxypropane-1,2,3-tricarboxylate

2.1.2 InChI

InChI=1S/C13H22N4O3S.C6H8O7.Bi/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3;7-3(8)1-6(13,5(11)12)2-4(9)10;/h4-5,9,14-15H,6-8,10H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;;+3/p-3

2.1.3 InChI Key

XAUTYMZTJWXZHZ-UHFFFAOYSA-K

2.1.4 Canonical SMILES

CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Bi+3]

2.2 Other Identifiers

2.2.1 UNII

7AJ51I17KG

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Azanplus

2. Gr 122311x

3. Gr-122311x

4. Gr122311x

5. Pylorid

6. Raniberl

7. Tritec

2.3.2 Depositor-Supplied Synonyms

1. Ranitidine Bismutrex

2. Tritec

3. Gr 122311x

4. Gr-122311x

5. 7aj51i17kg

6. 128345-62-0

7. Ranitidine (bismuth Citrate)

8. Azamplus

9. Elicodil

10. Helirad

11. Pylorisan

12. Unii-7aj51i17kg

13. Ranitidine Bismuth Citrate [usan]

14. Ranitidine Bismuth Citrate [usan:ban]

15. Schembl415304

16. Chembl2111286

17. Dtxsid801027716

18. Ranitidine Bismuth Citrate [mi]

19. N-(2-((5-((dimethylamino)methyl)furfuryl)thio)ethyl)-n'-methyl-2-nitro-1,1-ethenediamine, Compound With Bismuth(3(+)) Citrate (1:1)

20. Ranitidine Bismuth Citrate [vandf]

21. Ranitidine Bismuth Citrate [mart.]

22. Ranitidine Bismuth Citrate [who-dd]

23. Ranitidine Bismuth Citrate [orange Book]

24. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Bismuth(3(+)) Salt (1:1), Compd. With N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-n'-methyl-2-nitro-1,1-ethenediamine (1:1)

25. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Bismuth(3+) Salt (1:1), Compd. With N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-n'-methyl-2-nitro-1,1-ethenediamine (1:1)

26. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Bismuth(3+) Salt, Compd. With N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-n'-methyl-2-nitro-1,1-ethenediamine (1:1:1)

27. N-(2-((5-((dimethylamino)methyl)furfuryl)thio)ethyl)-n'-methyl-2-nitro-1,1-ethenediamine, Compound With Bismuth(3+) Citrate (1:1)

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₁₉H₂₇BiN₄O₁₀S
Molecular Weight	712.5 g/mol
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	14
Rotatable Bond Count	11
Exact Mass	712.12519 g/mol
Monoisotopic Mass	712.12519 g/mol
Topological Polar Surface Area	252 Å²
Heavy Atom Count	35
Formal Charge	0
Complexity	558
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	1
Covalently Bonded Unit Count	3

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Histamine H2 Antagonists

Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)

Anti-Ulcer Agents

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)

4.2 ATC Code

A - Alimentary tract and metabolism

A02 - Drugs for acid related disorders

A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)

A02BA - H2-receptor antagonists

A02BA07 - Ranitidine bismuth citrate

FDF Dossiers